Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-18

Clinical Trial Update: Mechanisms of Diuretic Resistance in Heart Failure, Aim 2 [Phase 1]

View source ↗

Summary

This Yale University clinical study outlines Aim 2 of a Phase 1 trial investigating the mechanisms of diuretic resistance in heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diuretic agents (diuretic agents)

Snippet

Sponsor: Yale University | Conditions: Heart Failure | Phase 1 | Status: RECRUITING